# Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

> **NCT06849544** · PHASE2 · RECRUITING · sponsor: **Clinton Bahler** · enrollment: 22 (estimated)

## Conditions studied

- Prostate Cancer Surgery
- Prostate Cancer Metastatic Disease

## Interventions

- **DRUG:** 0.03mg/kg ZOPOCIANINE given day of surgery
- **DRUG:** 0.06mg/kg ZOPOCIANINE given day of surgery
- **DRUG:** 0.03mg/kg ZOPOCIANINE given day prior to surgery
- **DRUG:** 0.06mg/kg ZOPOCIANINE given days prior to surgery

## Key facts

- **NCT ID:** NCT06849544
- **Lead sponsor:** Clinton Bahler
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-02
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06849544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06849544, "Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06849544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*